Urinary tract infections (UTIs) caused by Escherichia coli have been historically managed
with oral antibiotics including the cephalosporins, fluoroquinolones and trimethoprim …

Background Fluoroquinolones and polymyxins (colistin) are considered as critical drugs for
human medicine. Antimicrobials of these classes are also used in swine production …

Escherichia coli sequence type (ST) 131 is considered a high-risk pandemic clone and
frequently extended-spectrum β-lactamase (ESBL)-producing clone that is strongly …

Objective Escherichia coli ST131 is a pandemic clone associated with multidrug resistance,
starting with beta-lactamase production and fluoroquinolone resistance in the first place …

Background The pandemic spread of antibiotic resistance increases the likelihood of
ineffective empirical therapy. The recently emerged fluoroquinolone-resistant Escherichia …

Urinary tract infections (UTIs) are one of the most common infection in children in Syria. This
study was conducted on 48 urine samples from pediatric UTI patients aged from 0 days to 18 …

Escherichia coli ST131 is a cause for global concern because of its high multidrug
resistance and several virulence factors. In this study, the contribution of acrAB–TolC efflux …

Background: Antibiotic prescription practices differ between countries, influencing regional
antimicrobial resistance prevalence. However, comparisons of clonal diversity among …

The Escherichia coli O25b-ST131, with its fluoroquinolone-resistant H30 subclone and its
nested ESBL CTX-M-15-associated H30-Rx subclone, is the most disseminated MDR and …

Objectives Bacterial features associated with recurrent urinary tract infections (RUTIs) due to
extended-spectrum β-lactamase-producingEscherichia coli (ESBL-E. coli) are not well …